Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Integra LifeSciences stock
Learn how to easily invest in Integra LifeSciences stock.
Integra LifeSciences Holdings is a medical devices business based in the US. Integra LifeSciences shares (IART) are listed on the NASDAQ and all prices are listed in US Dollars. Integra LifeSciences employs 3,800 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Integra LifeSciences
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – IART – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
Integra LifeSciences stock price (NASDAQ: IART)Use our graph to track the performance of IART stocks over time.
Integra LifeSciences shares at a glance
|Latest market close||$55.00|
|52-week range||$53.57 - $76.70|
|50-day moving average||$58.95|
|200-day moving average||$64.82|
|Wall St. target price||$72.57|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$1.87|
Buy Integra LifeSciences shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Integra LifeSciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Integra LifeSciences price performance over time
|1 week (2022-06-24)||0.94%|
|1 month (2022-06-03)||-9.36%|
|3 months (2022-04-01)||-17.32%|
|6 months (2022-01-03)||-19.60%|
|1 year (2021-07-02)||-21.32%|
|2 years (2020-07-02)||12.89%|
|3 years (2019-07-03)||55.08|
|5 years (2017-07-03)||1.68%|
Is Integra LifeSciences stock undervalued or overvalued?
Valuing Integra LifeSciences stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Integra LifeSciences's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Integra LifeSciences's P/E ratio
Integra LifeSciences's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 29x. In other words, Integra LifeSciences shares trade at around 29x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Integra LifeSciences's PEG ratio
Integra LifeSciences's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.3763. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Integra LifeSciences's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Integra LifeSciences's EBITDA
Integra LifeSciences's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $407.2 million.
The EBITDA is a measure of a Integra LifeSciences's overall financial performance and is widely used to measure a its profitability.
Integra LifeSciences financials
|Revenue TTM||$1.6 billion|
|Operating margin TTM||18.4%|
|Gross profit TTM||$977 million|
|Return on assets TTM||4.84%|
|Return on equity TTM||9.96%|
|Market capitalisation||$4.6 billion|
TTM: trailing 12 months
Integra LifeSciences share dividends
We're not expecting Integra LifeSciences to pay a dividend over the next 12 months.
Have Integra LifeSciences's shares ever split?
Integra LifeSciences's shares were split on a 2:1 basis on 3 January 2017. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Integra LifeSciences shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Integra LifeSciences shares which in turn could have impacted Integra LifeSciences's share price.
Integra LifeSciences share price volatility
Over the last 12 months, Integra LifeSciences's shares have ranged in value from as little as $53.57 up to $76.7. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Integra LifeSciences's is 1.0957. This would suggest that Integra LifeSciences's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Integra LifeSciences overview
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as asset management software and support, and after-market services. It also sells approximately 40,000 instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally.
Integra LifeSciences in the news
Integra LifeSciences to Host Second Quarter 2022 Financial Results Conference Call on July 27, 2022
Integra LifeSciences to Host Second Quarter 2022 Financial Results Conference Call on July 27, 2022
Shareholders in Integra LifeSciences Holdings (NASDAQ:IART) are in the red if they invested a year ago
Frequently asked questionsWhat percentage of Integra LifeSciences is owned by insiders or institutions?
Currently 13.08% of Integra LifeSciences shares are held by insiders and 92.316% by institutions. How many people work for Integra LifeSciences?
Latest data suggests 3,800 work at Integra LifeSciences. When does the fiscal year end for Integra LifeSciences?
Integra LifeSciences's fiscal year ends in December. Where is Integra LifeSciences based?
Integra LifeSciences's address is: 1100 Campus Road, Princeton, NJ, United States, 08540 What is Integra LifeSciences's ISIN number?
Integra LifeSciences's international securities identification number is: US4579852082 What is Integra LifeSciences's CUSIP number?
Integra LifeSciences's Committee on Uniform Securities Identification Procedures number is: 457985109
More guides on Finder
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
How to buy Warrantee (WRNT) stock when it goes public
Everything we know about the Warrantee IPO, plus information on how to buy in.
How to buy Treasure Global (TGL) stock when it goes public
Everything we know about the Treasure Global IPO, plus information on how to buy in.
How to buy BIOLIFE4D (SAVU) stock when it goes public
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
Ask an Expert